Dipeptidyl Peptidase IV, Human Placenta | 4709

Dipeptidyl Peptidase IV is a lymphocyte cell surface antigen which is increased during T-cell activation and is also expressed in other tissues, such as placenta, kidney, etc. It is an atypical serine protease which has been implicated in a variety of biological functions including diabetes, rheumatoid arthritis, T-cell activation, cell-to-cell adhesion, and recently in HIV infection.

4709 | Dipeptidyl Peptidase IV Human Placenta DataSheet

Biomolecule/Target: N/A

Synonyms: DPPIV, DPP4, Dipeptidylpeptidase-4

Alternates names: CD26, ADABP, ADCP2, DPPIV, TP103, DPP4, Dipeptidyl peptidase 4, Dipeptidyl peptidase IV, DPP IV, T-cell activation antigen CD26, Adenosine deaminase complexing protein 2, CD26 antigen.

Taglines: An antigenic enzyme associated with immune regulation, signal transduction and apoptosis.

NCBI Gene ID #: UniGeneHs.419815

NCBI Gene Symbol: EGF

Gene Source: N/A

Accession #: Q6QBS2

Recombinant: No

Source: Human Placenta

Purity by SDS-PAGEs: 98%

Assay: SDS-PAGE

Purity: N/A

Assay #2: HPLC

Endotoxin Level: N/A

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 350.0 kDa

Concentration: N/A

Appearance: Liquid

Physical form description: Frozen liquid in 2 mM Tris-HCl, pH 8.0.

Reconstitution Instructions: N/A

Amino acid sequence: N/A